死胎与母亲长期肾脏疾病风险增加相关:全国性队列研究
这项基于瑞典全国登记数据的队列研究纳入1973至2012年间单胎妊娠妇女,随访至2013年。
要点
- 有死胎史的女性慢性肾脏病风险升高(aHR 1.26, 95%CI 1.09-1.45)。
- 有死胎史的女性终末期肾病风险升高(aHR 2.25, 95%CI 1.55-3.25)。
- 排除子痫前期、小于胎龄儿及先天畸形相关死胎后关联仍持续。
核心结论
- 有死胎史的女性相比仅有活产者,慢性肾脏病和终末期肾病风险增加。
- 该关联独立于子痫前期、小于胎龄儿、吸烟、肥胖及内科合并症。
研究设计与样本
- 基于瑞典医学出生登记、国家患者登记和瑞典肾脏登记的全國性人群队列研究。
- 纳入1973至2012年所有活产和死胎,随访至2013年,排除孕前肾脏疾病。
- 共1,941,057名女性、3,755,444次单胎妊娠,随访42,313,758人年,中位随访20.7年(IQR 9.9-30.0年)。
- 采用Cox比例风险回归模型估计调整风险比(aHR)及95%置信区间。
主要发现
- 13,032名女性(0.7%)至少发生1次死胎。
- 至少1次死胎者慢性肾脏病风险aHR 1.26(95%CI 1.09-1.45)。
- 至少1次死胎者终末期肾病风险aHR 2.25(95%CI 1.55-3.25)。
- 排除子痫前期、小于胎龄儿或先天畸形相关死胎后,慢性肾脏病aHR 1.33(95%CI 1.13-1.57),终末期肾病aHR 2.95(95%CI 1.86-4.68)。
- 在有内科合并症的女性中,死胎与慢性肾脏病(aHR 1.13, 95%CI 0.73-1.75)或终末期肾病(aHR 1.49, 95%CI 0.78-2.85)无显著关联。
临床怎么用
- 对有无明确原因死胎史的女性,应关注长期肾脏疾病风险,考虑更密切的随访监测。
局限性
- 需要进一步研究确定有死胎史的女性是否能从更密切的肾脏疾病监测和随访中获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stillbirth is a devastating adverse pregnancy outcome that may occur without any obvious reason or may occur in the context of fetal growth restriction, preeclampsia, or other obstetric complications. There is increasing evidence that women who experience stillbirths are at greater risk of long-term cardiovascular disease, but little is known about their risk of chronic kidney disease and end-stage renal disease. We conducted the largest study to date to investigate the subsequent risk of maternal chronic kidney disease and end-stage renal disease following stillbirth. OBJECTIVE: To identify whether pregnancy complicated by stillbirth is associated with subsequent risk of maternal chronic kidney disease and end-stage renal disease, independent of underlying medical or obstetric comorbidities. STUDY DESIGN/METHODS: We conducted a population-based cohort study using nationwide data from the Swedish Medical Birth Register, National Patient Register, and Swedish Renal Register. We included all women who had live births and stillbirths from 1973 to 2012, with follow-up to 2013. Women with preexisting renal disease were excluded. Cox proportional hazard regression models were used to estimate adjusted hazard ratios and 95% confidence intervals for associations between stillbirth and maternal chronic kidney disease and end-stage renal disease respectively. We controlled for maternal age, year of delivery, country of origin, parity, body mass index, smoking, gestational diabetes, preeclampsia, and small for gestational age deliveries. Women who had a history of medical comorbidities, which may predispose to renal disease (prepregnancy cardiovascular disease, hypertension, diabetes, lupus, systemic sclerosis, hemoglobinopathy, or coagulopathy), were excluded from the main analysis and examined separately. RESULTS: There were 1,941,057 unique women who had 3,755,444 singleton pregnancies, followed up over 42,313,758 person-years. The median follow-up time was 20.7 years (interquartile range, 9.9-30.0 years). 13,032 women (0.7%) had at least 1 stillbirth. Women who had experienced at least 1 stillbirth had a greater risk of developing chronic kidney disease (adjusted hazard ratio, 1.26; 95% confidence interval, 1.09-1.45) and end-stage renal disease (adjusted hazard ratio, 2.25; 95% confidence interval, 1.55-3.25) compared with women who only had live births. These associations persisted after removing all stillbirths that occurred in the context of preeclampsia, and small for gestational age or congenital malformations (for chronic kidney disease, adjusted hazard ratio, 1.33; 95% confidence interval, 1.13-1.57; for end-stage renal disease, adjusted hazard ratio, 2.95; 95% confidence interval, CI 1.86-4.68). There was no significant association observed between stillbirth and either chronic kidney disease or end-stage renal disease in women who had preexisting medical comorbidities (chronic kidney disease, adjusted hazard ratio, 1.13; 95% confidence interval, 0.73-1.75 or end-stage renal disease, adjusted hazard ratio, 1.49; 95% confidence interval, 0.78-2.85). CONCLUSION: Women who have a history of stillbirth may be at increased risk of chronic kidney disease and end-stage renal disease compared with women who have only had live births. This association persists independently of preeclampsia, and small for gestational age, maternal smoking, obesity, and medical comorbidities. Further research is required to determine whether affected women would benefit from closer surveillance and follow-up for future renal disease.
引用
- Barrett PM, McCarthy FP, Evans M, et al. Stillbirth is associated with increased risk of long-term maternal renal disease: a nationwide cohort study. Am J Obstet Gynecol. 2020. PMID: 32112729. doi:10.1016/j.ajog.2020.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。